Pejman Ghanouni, MD, PhD, New Interim Division Chief of Body MRI

Pejman Ghanouni, MD, PhD

September 13, 2021

On behalf of the Stanford Department of Radiology, we are pleased to to announce that Dr. Pejman Ghanouni, Associate Professor of Radiology, has been appointed as Interim Division Chief of Body MRI, effective August 1, 2021. 

Dr. Ghanouni received his AB degree, magna cum laude, in Biochemistry in 1993 and AM degree in Biology in 1994, both from Harvard University. He enrolled in the joint MD-PhD program at Stanford School of Medicine, earning his PhD degree in Molecular and Cellular Physiology (under Dr. Brian Kobilka) in 2001 and M.D. degree in 2005. He remained at Stanford to complete his Diagnostic Radiology residency in 2010, serving as Chief Resident in 2008-09, and a NCI Clinical Imaging Research fellowship in 2011, mentored by Dr. Kim Butts Pauly.

Dr. Ghanouni joined our Body MRI division as an Assistant Professor in 2012 and was promoted to Associate Professor in 2020. He is an internationally recognized leader in MR-guided high intensity focused ultrasound and established the Minimally Invasive MR Interventional Center (MIMRIC) at Stanford, serving as its Director. This Center, designated as a Center of Excellence by the Focused Ultrasound Foundation, develops MRI techniques to guide procedures, including biopsies and ablations. He has successfully amended the National Comprehensive Cancer Network guidelines to include image-guided ablation as a treatment option for desmoid tumors. 

His scholarly work has defined the field of MR-guided high-intensity focused ultrasound, which uses MR imaging to guide ultrasound delivered thermotherapy to treat disease. He has been protocol director of numerous clinical trials testing new applications of this technology, including leading Stanford’s effort to establish MRgFUS through large multi-institutional trials for the treatment of uterine fibroids, osseous metastases, and essential tremor. Currently, he is leading clinical trials at Stanford investigating the use of MRgFUS for new applications, including the treatment of prostate cancer, Parkinson disease, osteoid osteoma, and pancreatic cancer. 

In recognition of Dr. Ghanouni’s leadership in pioneering clinical applications of MRgFUS, he was recognized as Honorary President of the 2018 International Symposium on Focused Ultrasound. He is a board member of International Society for Therapeutic Ultrasound and serves as editorial board for the International Journal of Hyperthermia and on the board for the European Focused Ultrasound Society.

We want to thank Dr. Shreyas Vasanawala for leading Body MRI since 2011 as its first division chief, growing the division to five full-time faculty members. His leadership and efforts have established the Body MRI division as a center for clinical excellence. We are confident that Dr. Ghanouni will continue to provide leadership in the division’s national eminence.